瘤衍生的细胞外囊泡:它们如何调解质瘤免疫抑制
Tianfei Ma1, Gang Su2, Qionghui Wu1
1Lanzhou University Second Hospital, Lanzhou University, Lanzhou, China.
Molecular biology reports
|January 28, 2024
概括
质瘤衍生的细胞外囊泡 (EVs) 通过抑制免疫系统来促进瘤生长. 这些EV重编程免疫细胞,创造一个免疫抑制瘤微环境,阻碍有效的质瘤治疗和免疫疗法.
科学领域:
- 神经瘤学神经瘤学
- 免疫学 免疫学 免疫学
- 癌症生物学 癌症生物学
背景情况:
- 质瘤是具有不良预后的侵袭性脑瘤,部分原因是治疗耐药性和高度免疫抑制的瘤免疫微环境 (TIME).
- 质瘤释放的细胞外囊泡 (EVs) 在调节时间方面发挥着关键作用,有助于免疫逃避和治疗挑战.
研究的目的:
- 研究由质瘤衍生的EVs损害免疫细胞功能和促进免疫抑制的机制.
- 阐明针对新型质瘤免疫疗法策略的EV向潜力.
主要方法:
- 在瘤衍生的EVs的背景下分析免疫细胞群和功能.
- 以EV为媒介的免疫细胞重编程的表征,包括髓质衍生抑制细胞 (MDSC),调节性T细胞 (Tregs) 和瘤相关巨细胞 (TAMs).
主要成果:
- 质瘤EVs诱导TAMs采用亲瘤原始表型并促进MDSC激活.
- EVs损害树突细胞 (DC) 抗原处理和淋巴细胞激活,导致CD4+和CD8+T细胞数量减少和Tregs增加.
- 这导致了对抗瘤免疫力不利的全身免疫抑制状态.
结论:
- 脑瘤衍生的EV是脑瘤微环境中免疫抑制的关键调解者.
- 了解EV介导的免疫调节对于开发有效的质瘤免疫疗法至关重要.
更多相关视频
08:02In Vivo Immunogenicity Screening of Tumor-Derived Extracellular Vesicles by Flow Cytometry of Splenic T Cells
Published on: September 23, 2021
2.6K
11:15A Preclinical Mouse Model of Osteosarcoma to Define the Extracellular Vesicle-mediated Communication Between Tumor and Mesenchymal Stem Cells
Published on: May 6, 2018
10.2K
相关概念视频
Tumor Immunotherapy
526
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
526
The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
